1.Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments.
Takashi MITAMURA ; Hidemichi WATARI ; Yukiharu TODO ; Tatsuya KATO ; Yosuke KONNO ; Masayoshi HOSAKA ; Noriaki SAKURAGI
Journal of Gynecologic Oncology 2014;25(4):301-305
OBJECTIVE: According to the International Federation of Gynecology and Obstetrics staging, some surgeons perform lymphadenectomy in all patients with early stage endometrial cancer to enable the accurate staging. However, there are some risks to lymphadenectomy such as lower limb lymphedema. The aim of this study was to investigate whether preoperative assessment is useful to select the patients in whom lymphadenectomy can be safely omitted. METHODS: We evaluated the risk of lymph node metastasis (LNM) using LNM score (histological grade, tumor volume measured in magnetic resonance imaging [MRI], and serum CA-125), myometrial invasion and extrautrerine spread assessed by MRI. Fifty-six patients of which LNM score was 0 and myometrial invasion was less than 50% were consecutively enrolled in the study in which a lymphadenectomy was initially intended not to perform. We analyzed several histological findings and investigated the recurrence rate and overall survival. RESULTS: Fifty-one patients underwent surgery without lymphadenectomy. Five (8.9%) who had obvious myometrial invasion intraoperatively underwent systematic lymphadenectomy. One (1.8%) with endometrial cancer which was considered to arise from adenomyosis had para-aortic LNM. Negative predictive value of deep myometrial invasion was 96.4% (54/56). During the mean follow-up period of 55 months, one patient with deep myometrial invasion who refused an adjuvant therapy had tumor recurrence. The overall survival rate was 100% during the study period. CONCLUSION: This preoperative assessment is useful to select the early stage endometrial cancer patients without risk of LNM and to safely omit lymphadenectomy.
Adult
;
Aged
;
CA-125 Antigen/blood
;
Endometrial Neoplasms/pathology/*surgery
;
Female
;
Humans
;
*Lymph Node Excision
;
Lymphatic Metastasis
;
Magnetic Resonance Imaging/methods
;
Middle Aged
;
Neoplasm Invasiveness
;
Neoplasm Recurrence, Local
;
Neoplasm Staging
;
Postoperative Care/methods
;
Preoperative Care/methods
;
Prognosis
;
Survival Analysis
;
Unnecessary Procedures
2.Multivariate survival analysis of the patients with recurrent endometrial cancer.
Tetsuji ODAGIRI ; Hidemichi WATARI ; Masayoshi HOSAKA ; Takashi MITAMURA ; Yousuke KONNO ; Tatsuya KATO ; Noriko KOBAYASHI ; Satoko SUDO ; Mahito TAKEDA ; Masanori KANEUCHI ; Noriaki SAKURAGI
Journal of Gynecologic Oncology 2011;22(1):3-8
OBJECTIVE: Few studies on the prognosticators of the patients with recurrent endometrial cancer after relapse have been reported in the literature. The aim of this study was to determine the prognosticators after relapse in patients with recurrent endometrial cancer who underwent primary complete cytoreductive surgery and adjuvant chemotherapy. METHODS: Thirty-five patients with recurrent endometrial cancer were included in this retrospective analysis. The prognostic significance of several clinicopathological factors including histologic type, risk for recurrence, time to relapse after primary surgery, number of relapse sites, site of relapse, treatment modality, and complete resection of recurrent tumors were evaluated. Survival analyses were performed by Kaplan-Meier curves and the log-rank test. Independent prognostic factors were determined by multivariate Cox regression analysis. RESULTS: Among the clinicopathological factors analyzed, histologic type (p=0.04), time to relapse after primary surgery (p=0.03), and the number of relapse sites (p=0.03) were significantly related to survival after relapse. Multivariate analysis revealed that time to relapse after primary surgery (hazard ratio, 6.8; p=0.004) and the number of relapse sites (hazard ratio, 11.1; p=0.002) were independent prognostic factors for survival after relapse. Survival after relapse could be stratified into three groups by the combination of two independent prognostic factors. CONCLUSION: We conclude that time to relapse after primary surgery, and the number of relapse sites were independent prognostic factors for survival after relapse in patients with recurrent endometrial cancer.
Endometrial Neoplasms
;
Female
;
Humans
;
Multivariate Analysis
;
Recurrence
;
Retrospective Studies
;
Survival Analysis*
3.Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy.
Tatsuya KATO ; Hidemichi WATARI ; Mahito TAKEDA ; Masayoshi HOSAKA ; Takashi MITAMURA ; Noriko KOBAYASHI ; Satoko SUDO ; Masanori KANEUCHI ; Masataka KUDO ; Noriaki SAKURAGI
Journal of Gynecologic Oncology 2013;24(3):222-228
OBJECTIVE: The aim of this study was to investigate the prognostic factors and treatment outcome of patients with adenocarcinoma of the uterine cervix who underwent radical hysterectomy with systematic lymphadenectomy. METHODS: A total of 130 patients with stage IB to IIB cervical adenocarcinoma treated with hysterectomy and systematic lymphadenectomy from 1982 to 2005 were retrospectively analyzed. Clinicopathological data including age, stage, tumor size, the number of positive node sites, lymphovascular space invasion, parametrial invasion, deep stromal invasion (>2/3 thickness), corpus invasion, vaginal infiltration, and ovarian metastasis, adjuvant therapy, and survival were collected and Cox regression analysis was used to determine independent prognostic factors. RESULTS: An estimated five-year survival rate of stage IB1 was 96.6%, 75.0% in stage IB2, 100% in stage IIA, and 52.8% in stage IIB. Prognosis of patients with one positive-node site is similar to that of those with negative-node. Prognosis of patients with multiple positive-node sites was significantly poorer than that of negative and one positive-node site. Multivariate analysis revealed that lymph node metastasis, lymphovascular space invasion, and parametrial invasion were independent prognostic factors for cervical adenocarcinoma. Survival of patients with cervical adenocarcinoma was stratified into three groups by the combination of three independent prognostic factors. CONCLUSION: Lymph node metastasis, lymphovascular space invasion, and parametrial invasion were shown to be independent prognostic factors for cervical adenocarcinoma treated with hysterectomy and systematic lymphadenectomy.
Adenocarcinoma
;
Cervix Uteri
;
Female
;
Humans
;
Hysterectomy
;
Lymph Node Excision
;
Lymph Nodes
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Prognosis
;
Retrospective Studies
;
Survival Rate
;
Treatment Outcome
;
Uterine Cervical Neoplasms